Stock comparison
ELI LILLY & Co is 27.5x more valuable than ALNYLAM PHARMACEUTICALS, INC. by market capitalization ($1.142 T vs $41.48 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
LLY is larger
ELI LILLY & Co is 27.5x more valuable than ALNYLAM PHARMACEUTICALS, INC. by market capitalization ($1.142 T vs $41.48 B).
Market value leader
LLY
ELI LILLY & Co is 27.5x more valuable than ALNYLAM PHARMACEUTICALS, INC. by market capitalization ($1.142 T vs $41.48 B).
Revenue leader
LLY
ALNY: $3.71B vs LLY: $65.18B.
Profit leader
LLY
ALNY: $313.75M vs LLY: $20.64B.
Margin leader
LLY
ALNY: 8.4% vs LLY: 31.7% net margin.
| Metric | ALNY | LLY |
|---|---|---|
| Market cap | $41.48 B | $1.142 T |
| US-listed rank | #374 | #10 |
| Revenue (latest FY) | $3.71B | $65.18B |
| Net income (latest FY) | $313.75M | $20.64B |
| Net margin | 8.4% | 31.7% |
| P/E (trailing FY) | 132.2x | 55.3x |
| SEC filings | 1,651 | 995 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ELI LILLY & Co is 27.5x more valuable than ALNYLAM PHARMACEUTICALS, INC. by market capitalization ($1.142 T vs $41.48 B).
In their latest fiscal years, ALNYLAM PHARMACEUTICALS, INC. reported $3.71B in revenue while ELI LILLY & Co reported $65.18B.
Full pages: ALNYLAM PHARMACEUTICALS, INC. and ELI LILLY & Co, or browse the full rankings.